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Abstract
The present chapter critically reviews scientiﬁc evidence on the impact of the diet
and its components on the metabolic control, cardiovascular risk factors, and
morbidity/mortality in diabetic patients.
Three main topics are included in this chapter: (1) the effects of dietary
treatment on body weight control in diabetic patients; (2) the optimal dietary
composition in order to achieve blood glucose control and reduce other cardio-
vascular risk factors associated with type 2 diabetes; (3) the effects of lifestyle
modiﬁcations and dietary changes on the risk to develop type 2 diabetes.
The overall body of evidence seems to conﬁrm the efﬁcacy of current recom-
mendations for diabetes management. However, although dietary strategies based
on structured interventions are often successful, particularly in relation to body
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weight control, they are not easily applicable in clinical practice and, therefore,
more feasible strategies should be identiﬁed.
In addition, further intervention studies focused on the effects of lifestyle on
hard endpoints in diabetic subjects are needed to deﬁnitively prove the role of diet
in the prevention of both cardiovascular and microvascular complications in these
patients over and above their impact on weight reduction.
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Dietary Treatment of Type 2 Diabetes
Weight Loss
Weight gain is a major problem for people with type 2 diabetes. The results of the
Third National Health and Nutrition Examination Survey (NHANES III) have
indicated that the 85.2% of diabetic people were overweight or obese, and the
54.8% were obese, during the years 1999–2002 (Flegal et al. 2002); so, most adults
with diabetes are overweight or obese. In addition, it is important to underline that
body weight increases with age, and widely prescribed oral hypoglycemic drugs
facilitate weight gain. Therefore, encouraging patients to achieve and maintain a
healthy weight should be a priority for all diabetes care programs.
In overweight and obese patients with type 2 diabetes, modest and sustained
weight loss has been shown to improve glycemic control (by reducing insulin
resistance) and plasma lipid, and to reduce blood pressure levels, the need for
glucose-lowering, blood pressure, and lipids medications, and cardiovascular mor-
tality (UK Prospective Diabetes Study 1990; Goldstein 1992; Pastors et al. 2002;
Wing et al. 2013; Look AHEAD Research Group 2014).
In particular for mortality, an observational study conducting in the United States
and involving 4970 overweight people with diabetes (body mass index – BMI
27 kg/m2) has showed that an intentional weight loss is associated with a reduction
in total mortality of 25% and in diabetes-related and cardiovascular mortality of 28%
(Williamson et al. 2000). But, in the same study, the authors also report an U-shaped
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relationship between mortality and weight loss; more in detail, the authors show that
a body weight reduction 30% is associated with slightly increased of mortality
(Williamson et al. 2000).
In order to improve blood glucose control and reduce body weight and waist
circumference, some studies have demonstrated that an intensive dietary interven-
tion, based on the nutritional recommendations for people with diabetes, is more
effective than usual care, in particular in diabetic patients not adequately controlled
despite an optimized hypoglycemic drug treatment (Coppell et al. 2010). However, it
is important to underline that among overweight or obese patients with type 2
diabetes and inadequate glycemic, blood pressure, and lipid control and/or other
obesity-related medical conditions, lifestyle changes that include diet, exercise, and
daily/weekly contacts with health professionals are the most effective interventions,
as demonstrated by the Look AHEAD trial (Look AHEAD Research Group 2010
and 2014). The Look AHEAD trial is the ﬁrst study that has investigated the effects
of a moderate body weight reduction, obtained by an intensive lifestyle intervention
combining a moderate energy restriction with a signiﬁcant increase of the habitual
physical activity, on cardiovascular risk factors and the incidence of cardiovascular
events and mortality in a large cohort of overweight and obese individuals with type
2 diabetes. In relation to the cardiovascular risk factors, this study has shown that an
intensive lifestyle intervention, compared with an usual education program, repre-
sents a good strategy to reduce body weight, improve signiﬁcantly blood pressure
and blood glucose control also in long-term (4 years of follow-up) (Look AHEAD
Research Group 2010 and 2014). In addition, in a small number of patients, the
intervention has been able to induce a partial or total remission of diabetes. Partic-
ularly remarkable is the effect on HDL-cholesterol (HDL-chol), with an increase
greater at 4 years than at 1 year. More in detail, in the lifestyle group the HDL-chol
was approximately 8–9% higher at each year than the baseline levels, whereas in the
control group it remained at 3–6% above baseline. Interestingly, although severely
obese participants did not reach their ideal body weight, a signiﬁcant reduction of
blood pressure, plasma glucose, HbA1c, and triglycerides was achieved, conﬁrming
the beneﬁts of moderate weight loss (7–10% of initial body weight) in the manage-
ment of diabetes (Look AHEAD Research Group 2010 and 2014).
Although this approach is clinically meaningful, it is not easily applicable in
clinical practice for the great investments in terms of economic and professional
resources; thus, more feasible strategies should be identiﬁed, considering that there
is no single intervention or pattern of interventions suitable for all; weight reducing
strategies should be tailored to the individual needs.
To date, studies demonstrating the beneﬁts of weight reduction in people with
type 2 diabetes are largely of short duration (up to 6 months); moreover, it is known
the effort to keep over time the weight loss, particularly in the absence of the
intensive support provided in a clinical trial. Usually, successful individuals can
lose approximately 10% of baseline body weight with a hypocaloric regimen,
though many regain one-third of this in the following year and all the weight loss
within 5 years. Experience in the US National Weight Control Registry suggests that
most people who successfully lose weight and maintain weight loss have
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experienced a triggering event such as an acute medical condition, so it is possible
that a new diagnosis of type 2 diabetes could help to motivate an individual to lose
weight (Wing and Phelan 2005).
Very low calorie diets, providing only 800 kcal/day, produce rapid weight loss but
are not more effective of conventional diets in the long term; they should be reserved
for people with severe obesity (BMI 35 kg/m2) as part of a supervised weight
management program. Nowadays, a 10 kg weight loss in the ﬁrst 3–6 months, or
1–2 kg per month, has been proposed for people with diabetes. This weight loss can
be attained with lifestyle programs that achieve a 500–750 kcal/day energy deﬁcit or
provide approximately 1200–1500 kcal/day for women and 1500–1800 kcal/day for
men, adjusted for the individual’s baseline body weight. In older people with
diabetes, since body weight tends to increase with age, weight stabilization may be
a more appropriate strategy.
Optimal Diet Composition
Nutrition therapy has an integral role in overall diabetes management and has the
following goals:
– To control plasma glucose levels
– To prevent hypoglycemia, if the patient is treated with oral hypoglycemic drugs
or with insulin
– To achieve and maintain a normal body weight
– To prevent or delay complications
– To control blood lipid levels and blood pressure
– To improve the quality of life
The current nutritional recommendations for people with diabetes emphasize the
healthful eating patterns containing nutrient-dense, high-quality foods and a focus on
speciﬁc nutrients. In this context, the Mediterranean diet (Estruch et al. 2013),
dietary approaches to stop hypertension (DASH) (Cespedes et al. 2016; Ley et al.
2014), and plant-based diets (Rinaldi et al. 2016) are all examples of healthful eating
patterns for people with diabetes, and the “Plate model” could be an example of the
simple method applying these recommendations in daily life.
Current dietary recommendations for diabetic patients are particularly focused on
optimizing the quantities and food sources of fat and carbohydrates within the same
recommendations for healthy eating that applies to the general population. The
composition of the diet recommended for people with diabetes is listed in Table 1
(American Diabetes Association 2017; Mann et al. 2004). These recommendations
should take into account individual nutrition needs based on personal and cultural
preferences, health literacy and numeracy, and access to healthful foods.
Fats
Total fat intake should be reduced to provide no more than 35% of energy. The type
of fats consumed is more important than total amount of fat when looking at
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metabolic goals and CVD risk (Ofﬁce of Disease Prevention and Health Promotion
2015–2020; Estruch et al. 2013; Ros 2003; Forouhi et al. 2016; Wang et al. 2016).
Therefore, the fat content of the diet should be manipulated to reduce intake of fats
which promote alterations in plasma lipid proﬁle. In particular, saturated and trans
fatty acids (found in meat and dairy products, and in hard margarines, some salad
Table 1 Medical Nutrition Therapy recommendations for people with diabetes from Scientiﬁc
Associations of Diabetes specialists
Topic
Speciﬁc
intakea Recommendationsb
Energy
balance
– • Modest weight loss achievable by the combination of
reduction of calorie intake and lifestyle modiﬁcation
beneﬁts overweight or obese adults with type 2 diabetes
and those with prediabetes. Intervention programs to
facilitate this process are recommended
Dietary
carbohydrates
Added sugar
Fiber
45–60% of
TE
<10% of TE
>20 g/
1000 kcal
• Carbohydrate intake from whole grains, vegetables, fruits,
legumes, and dairy products, with an emphasis on foods
higher in ﬁber and lower in glycemic load, should be
advised over other sources, especially those containing
sugars.
• People with diabetes and those at risk should avoid sugar-
sweetened beverages in order to control weight and reduce
their risk for CVD and fatty liver B and should minimize
the consumption of foods with added sugar that have the
capacity to displace healthier, more nutrient-dense food
choices
Dietary fat
SAFA
MUFA
PUFA
Cholesterol
<35% of TE
<10% of TE
10–20% of
TE
<10% of TE
<300 mg/day
• Whereas data on the ideal total dietary fat content for
people with diabetes are inconclusive, an eating plan
emphasizing elements of a Mediterranean-style diet rich in
monounsaturated fats may improve glucose metabolism
and lower CVD risk and can be an effective alternative to a
diet low in total fat but relatively high in carbohydrates.
• Eating foods rich in long-chain v-3 fatty acids, such as
fatty ﬁsh (EPA and DHA) and nuts and seeds (ALA) is
recommended to prevent or treat CVD; however, evidence
does not support a beneﬁcial role for v-3 dietary
supplements
Protein 10–20% of
TE
• In individuals with type 2 diabetes, ingested protein
appears to increase insulin response without increasing
plasma glucose concentrations. Therefore, carbohydrate
sources high in protein should not be used to treat or
prevent hypoglycemia
Sodium 2300 mg/day • As for the general population, people with diabetes should
limit sodium consumption to 2300 mg/day, although
further restriction may be indicated for those with both
diabetes and hypertension
TE total energy, SAFA saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsat-
urated fatty acids
aEvidence-based nutritional approaches to the treatment and prevention of diabetes mellitus.
Diabetes and Nutrition Study Group (DNSG), 2004
bAmerican Diabetes Association. Standards of Medical Care in Diabetes 2017
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dressing, and processed foods, respectively) should provide no more than 10% of
total energy and dietary cholesterol should be limited to less than 300 mg/day (and
less than 200 mg/day in people with alteration of lipid metabolism).
Recommendations for the dietary content of other fats reﬂect a balance between
their favorable and adverse metabolic effects. Cis-monounsaturated fats (found in
olive oil, peanut oil, sunﬂower oil, almonds, avocado) have a more favorable
metabolic impact and may reduce insulin-resistance and plasma LDL-cholesterol
concentrations as compared with saturated fat (Vessby et al. 2001). When they
replace carbohydrate in a weight-maintaining diet, these fats are also associated
with lower postprandial glycaemia and plasma triglyceride levels. They should
nevertheless be limited because they are energy-dense and may cause weight gain,
and in large amounts, increase insulin resistance.
Polyunsaturated fatty acids of n-3 series (found in ﬁsh and soybean oils) have
favorable effects on plasma triglyceride levels and antithrombotic activity but may
increase plasma LDL-cholesterol concentrations if consumed in large amounts,
usually at pharmacological doses. Dietary n-6 polyunsaturated fatty acids are asso-
ciated with reduced total and LDL-cholesterol compared with a diet high in saturated
fat. Their hypocholesterolemic effect is slightly higher than that achieved with
similar amounts of monounsaturated fat; in addition, they have also a small hypo-
triglyceridemic effect; however, they tend to decrease HDL cholesterol (Ooi et al.
2013).
Carbohydrates
Dietary carbohydrates represent the largest contributor to the energy intake in most
countries and the main dietary component able to inﬂuence blood glucose levels,
particularly in the postprandial state. Therefore, their intake is considered extremely
important in the regulation of blood glucose levels in people with diabetes.
In the last few years, the debate on the pros and cons of carbohydrate-rich diets
has been very hot on the basis of the possible unfavorable effects of dietary
carbohydrates on glycemic control and plasma lipid levels, in particular on increase
of plasma triglycerides and decrease of plasma HDL-cholesterol. Many of these
controversies arise because it is not always recognized that carbohydrates are a
heterogeneous class of nutrients with marked differences in their rate of digestion,
absorption, and, therefore, on metabolic effects. So, in order to evaluate the variety
of the blood glucose response in vivo after a meal containing carbohydrates, it is
important to consider other important component, as the ﬁber content, the chemical
composition of carbohydrates, and the physical structure of the foods present in the
meal. To account for all these factors, Jenkins et al. (1981) introduced the concept of
the glycemic index (GI), which attempts to quantify the potency of carbohydrate
foods to raise blood glucose levels in vivo. Most trials that have compared the effects
of low-GI and high-GI diets have shown that low-GI foods have more favorable
effects on glycemic control (Riccardi et al. 2008). In nondiabetic populations, low-
GI diets have been associated with lower plasma levels of insulin and lipids and
improved glucose tolerance (Bell et al. 2015; Brand-Miller et al. 2009). In people
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with type 2 diabetes, a low-GI diet is associated with better glycemic control (as
indicated by lower HbA1C or fructosamine levels) (Brand-Miller et al. 2003;
Thomas and Elliott 2010). However, some studies have detected no difference
between low- and high-GI foods on plasma lipids in people with diabetes.
A recent meta-analysis comparing the effects of low-GI diets with conventional
or high-GI diets on glycemic control in patients with diabetes concluded that the
low-GI diets improve the glycemic control reducing HbA1C by about 6% (for
example, reducing an HbA1c of 8% to approximately 7.5%) (Wang et al. 2015).
This effect is very important in people with diabetes because it is known that HbA1c
is continuously related to the risk of diabetes complications, as demonstrated by the
results of the United Kingdom Prospective Diabetes Study (UKPDS) in which the
reduction of HbA1c by one percentage point was associated with a reduction of 21%
in diabetes-related deaths and complications (UK Prospective Diabetes Study
Group, 1998). Therefore, any reduction of glycated hemoglobin is welcome.
Based on this context, all nutritional recommendations available for people with
diabetes consider the GI of foods the most important parameters for carbohydrates
consumption. More in detail, European dietary recommendations state that “Carbo-
hydrate-containing foods which are high in dietary ﬁbre or have a low glycaemic
index are especially recommended” (The Task Force on diabetes, pre-diabetes, and
cardiovascular diseases 2013). The justiﬁcation for this stance is that low-GI foods
may help to improve glycemic control and lipid levels.
Also the American Diabetes Association and the UK recommendations recom-
mend the utilization of the GI in the diet for people with diabetes (American Diabetes
Association 2017; Dyson et al. 2011). However, according to ADA, it should always
be taken into account that many healthy foods have a higher GI than foods with little
nutritional value. For example, oatmeal has a higher GI than chocolate. Therefore, it
is important to remember that the GI represents the type of carbohydrate in a food but
says nothing about the amount of carbohydrate typically eaten. For this reason, the
glycemic load (GL) has been proposed as a marker of the impact of a food on
postprandial blood glucose since it takes into account both the amount of carbohy-
drate present in the portion of food eaten and the glycemic impact of that speciﬁc
food as compared with a reference food like white bread.
The glycemic load (GL) is calculated by multiplying the GI of a food by the
amount of carbohydrate in grams per serving and dividing the total by 100.
There are other important reasons for encouraging consumption of low-GI foods.
In general, foods with a low glycemic index tend to be high in ﬁber and micro-
nutrients – for example, legumes, oats, pasta, and some raw fruits have low GI values
(Atkinson et al. 2008).
Dietary Fibers
Intake of dietary ﬁber is associated with lower all-cause mortality in people with
diabetes. There is a large body of evidence that a diet moderately rich in carbohy-
drates and ﬁbers, and, consequently, with a low glycemic index and mainly based on
consumption of legumes, vegetables, fruits, and whole grain cereals improves blood
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glucose control and reduces plasma cholesterol levels in diabetic patients as com-
pared with a low carbohydrate-low ﬁber diet. In particular, this type of diet keeps low
plasma insulin and triglyceride concentrations despite its higher carbohydrate intake
and induces also a signiﬁcant reduction in postprandial blood glucose and triglyc-
eride rich lipoprotein levels which play a relevant role in modulating the cardiovas-
cular risk in patients with type 2 diabetes (De Natale et al. 2009). The net LDL-
cholesterol reduction due to the doubling of ﬁber intake can be more than 10%. The
beneﬁcial effects of high-ﬁber diets on LDL-cholesterol have been conﬁrmed by a
meta-analysis comparing the effects of low-GI vs. high-GI diets. The signiﬁcant
decrease in LDL-cholesterol observed with the low-GI diets was related to their ﬁber
content and, in fact, it was not any more evident when studies with high-ﬁber diets
were excluded from the analysis (Goff et al. 2013).
Dietary ﬁber seems able to counteract the rising effect of carbohydrates on fasting
triglycerides. In the last years, much attention has been paid to postprandial lipemia
as a cardiovascular risk factor and, indeed, large epidemiological studies suggest that
postprandial triglycerides are a stronger cardiovascular risk factor than fasting
triglyceride levels (Bansal et al. 2007). Different dietary components modulate the
postprandial triglyceride response. Recently, much attention has been devoted to the
effects of dietary ﬁber on postprandial triglycerides. In people with type 2 diabetes,
a ﬁber-rich diet reduces the postprandial triglyceride response, mainly due to the
reduction of lipoproteins carrying exogenous lipids. On the same line, a diet based
on wholegrain cereals, as compared to a diet with reﬁned cereals, reduces postpran-
dial triglyceride levels by 40% in people with the metabolic syndrome (Giacco et al.
2014). In this study, the decrease in postprandial triglycerides was signiﬁcantly and
inversely correlated with the intake of cereal ﬁber, supporting the role of cereal ﬁber
in the modulation of the postprandial metabolism.
The effects of dietary ﬁber on HDL-cholesterol are negligible. Together with the
reduction of LDL-cholesterol, a small decrease in HDL-cholesterol has been
reported with high-ﬁber diets in some studies; however, on the overall, the magni-
tude of this effect is much less relevant than that obtained on LDL-cholesterol.
Although solubility of ﬁber was thought to determine physiological effect, more
recent studies suggest that other properties of ﬁber, such as fermentability and
viscosity may be more important (Slavin 2013). As a matter of fact, dietary ﬁbers
improve glucose and lipid metabolism slowing food digestion and nutrient absorp-
tion and producing in the colon short-chain fatty acids that, in turn, modulate liver
glucose production and lipid synthesis. Therefore, people with diabetes should not
be excluded from the public health campaign that encourages eating ﬁve portions of
fruit and vegetables a day and promotes wholegrain cereal foods as a substitute for
the reﬁned ones. In addition, for diabetic patients it may be helpful, among the high
ﬁber foods, to tilt the balance of consumption in favor of those with a low GI.
Sugar
In the past, people with diabetes were recommended to completely avoid sugar. In fact,
it was believed that eating sugar would raise blood glucose. Conversely, available
scientiﬁc evidence from clinical studies shows that dietary sucrose inﬂuences blood
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glucose levels not more than an equivalent caloric amounts of starch. It is important to
underline that the excess of energy intake from nutritive sweeteners or foods and
beverages containing high amounts of nutritive sweeteners should be avoided, since
they provide “empty” calories and can lead to weight gain (Evert et al. 2013).
Fructose is a common naturally occurring monosaccharide found in fruits, in
some vegetables, and honey and is also widely used as sweetener of drink or added
in processed foods in substitution of sucrose. Fructose consumed as “free fructose”
(i.e., naturally occurring in foods such as fruit) may result in better glycemic control
compared with isocaloric intake of sucrose or starch, and free fructose is not likely to
have detrimental effects on triglycerides as long as its intake is kept low (less than
5% energy).
People with diabetes should limit or avoid intake of sugar-sweetened beverages
(SSBs) (from any caloric sweetener, including high-fructose corn syrup and sucrose)
to reduce the risk of weight gain and worsening the cardiometabolic proﬁle.
A meta-analysis of controlled intervention studies with a duration of less than
12 weeks in people with diabetes compared the impact of fructose with that of other
sources of carbohydrate on glycemic control (Cozma et al. 2012). The results
showed that an isocaloric exchange of fructose for other carbohydrates did not
signiﬁcantly affect fasting glucose or insulin and reduced glycated blood proteins.
However, strong evidence exists that consuming high levels of fructose-containing
beverages may have particularly adverse effects on selective deposition of visceral
fat, lipid metabolism, blood pressure, and insulin sensitivity (Evert et al. 2013).
Thus, recommendations for diabetic people about sugar intake should on the one
hand consider the unfeasibility of too stringent limitations of added sugar, particu-
larly for children but, on the other hand, should take into account potential metabolic
consequences of excessive consumption of sweetened foods and, even more, bev-
erages, particularly soft drinks, that could lead to further deterioration of insulin
resistance and obesity.
Protein
Protein intake in economically developed countries is high and exceeds metabolic
needs; in the United States, for example, it is estimated that protein accounts for
10–20% of the energy intake. Current recommended limits are based on a pragmatic
interpretation of the available evidence and awareness that attempts to restrict
protein intake below 0.6 g/kg/day may precipitate nutritional deﬁciency.
Protein does not affect the rate at which glucose is absorbed from a meal or
postprandial blood glucose levels. In people with type 1 diabetes and incipient
nephropathy, high protein intake may increase the progression of renal disease;
however, little is known about the effects of high protein consumption in people
with type 2 diabetes. Protein increases satiety; diets that are high in protein but low in
carbohydrate do achieve weight loss but not more so than other types of calorie
restriction diets. Furthermore, such diets tend to be high in fat and this may induce
plasma LDL-cholesterol increases. There is no evidence that high protein diets are
beneﬁcial in people with type 2 diabetes.
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There is no strong evidence to suggest higher beneﬁts from plant protein as compared
to animal protein; however, considering that foods as meat, processed meat, milk
products, eggs, although rich in essential aminoacids are also rich in saturated fats, it
is appropriate to limit animal protein intake (National Kidney Foundation 2012).
Diet and Cardiovascular Morbidity/Mortality
The inverse association between the adherence to a healthy diet (Mediterranean diet,
DASH diet, Prudent diet) and cardiovascular disease has been found in many large
prospective studies in nondiabetic populations (Soﬁ et al. 2010; Salehi-Abargouei et
al. 2013; Hu et al. 2000) and some data are available also for diabetic patients.
More in detail, a greater adherence to a healthy diet, characterized by high
consumption of whole-grains, vegetables, fruit, nuts, and ﬁsh compared to meat,
poultry, and eggs, is associated with a reduction by 20% of recurrent cardiovascular
events in a large cohort of patients with previous CVD and/or diabetes. These data
indicate that a healthy diet may be important not only in primary prevention but also
in secondary prevention or in high CV-risk individuals, such as diabetic patients.
Moreover, the beneﬁcial effects are in addition to those obtained with the pharma-
cological therapy generally used in secondary prevention (Dehghan et al. 2012).
The association between diet and mortality in type 1 diabetic subjects has been
investigated in the EURODIAB study that is the ﬁrst European prospective study on
this issue; the results have shown that, in a cohort of almost 2000 subjects, a 5 g-
increase of ﬁber intake, especially soluble ﬁber, within the range commonly con-
sumed in patients with type 1 diabetes (11.3–28.3 g/day) is associated with lower
CVD mortality (16%) and all-cause mortality (28%) (Schoenaker et al. 2012)
conﬁrming the importance of dietary ﬁbers in diabetes management also for what
concerns type 1 diabetes.
The casual relationship between diet and cardiovascular risk in type 2 diabetic
patients has been evaluated in the Look AHEAD trial (The Look AHEAD Research
Group 2013). This study has shown that an intensive lifestyle modiﬁcation program
focused on weight reduction is able to improve all cardiovascular risk factors, as
reported above, whereas does not reduce the occurrence of cardiovascular events and
mortality compared to the usual care group in the long term. Completely different are
the results obtained in the PREDIMED study (Estruch et al. 2013) which was not
focused on reducing excessive body weight but aimed exclusively at achieving
dietary modiﬁcations resembling the traditional Mediterranean diet. In fact, in this
study a Mediterranean diets supplemented with either extra-virgin olive oil or nuts
was able to reduce signiﬁcantly (almost 30%) the incidence of major CV events
compared to the control diet in high-risk individuals, including subjects with T2D
(n = 3614, almost 50% of the total population).
Although the early termination of the trial may lead to an overestimation of
treatment effects (Bassler et al. 2010), the results suggest that changes in diet
composition, even small, may be really effective, possibly more than weight reduc-
tion, in reducing CVD in type 2 diabetic subjects.
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Diet and Type 2 Diabetes Prevention
Diet represents the cornerstone of diabetes treatment since it can induce signiﬁcant
improvements of blood glucose control and other metabolic cardiovascular risk
factors (Franz et al. 2010; Lindström et al. 2006) and might potentially reduce the
risk of long-term complications (Laakso 1999). A healthy diet, as part of an
appropriate lifestyle, is also able to prevent type 2 diabetes. Studies using lifestyle
interventions in people with impaired glucose tolerance have shown a reduction in
diabetes incidence (Eriksson and Lindgärde 1991; Pan et al. 1997; Tuomilehto et al.
2001; Knowler et al. 2002; Ramachandran et al. 2006; Kosaka et al. 2005). Lifestyle
intervention in these studies lasting for 3–6 years emphasized body weight control
(weight reduction >5–10% of initial body weight), physical activity, and dietary
modiﬁcations such as a fat intake <30% of daily energy intake, saturated fat <10%
of daily energy intake, and a ﬁber intake >15 g/1000 kcal. In particular, both the
Finnish Diabetes Prevention Study (Tuomilehto et al. 2001) and the US Diabetes
Prevention Program (Knowler et al. 2002) showed a 58% relative risk reduction in
the progression from impaired glucose tolerance to type 2 diabetes, during a mean
intervention period of about 3 years.
Beside these studies focused on the effects of lifestyle modiﬁcations and dietary
changes on the risk to develop type 2 diabetes, several observational studies have
shown an association between consumption of speciﬁc food groups or healthy
dietary patterns and the risk of type 2 diabetes (Table 2). The EPIC-Potsdam
study, in line with previous studies, has conﬁrmed that higher intakes of whole-
grain bread, fruits, raw vegetables, and coffee are inversely associated with type 2
diabetes risk in a large cohort of healthy subjects, during an average follow-up of
8 years (vonRuesten et al. 2013). These foods are good sources of dietary ﬁber and
antioxidant, vitamins and minerals that could contribute to their protective role
against type 2 diabetes. In support of their role in diabetes prevention is also the
evidence that ﬁber rich foods have a lower impact on blood glucose levels after a
meal. Indeed all pharmacological (Chiasson et al. 2002) and nonpharmacological
interventions tested so far in people with pre-diabetes, able to reduce glycemia after
meals with whatever mechanism, have proven effective in the prevention of type 2
diabetes.
Conversely, high intakes of red meat, butter, sauces and fat dairy are associated
with an increased risk of type 2 diabetes (vonRuesten et al. 2013). Fish consumption
in some studies has been found to be associated with a lower risk of diabetes
(Nkondjock and Receveur 2003; Adler et al. 1994). Whether the protective effect
of ﬁsh is due to its n-3 fatty acid content or to other components, such as protein, is a
matter of debate. The mechanisms by which fat consumption could inﬂuence the
development of diabetes is strictly linked to insulin sensitivity. In fact, dietary fat can
inﬂuence insulin sensitivity independently of any change in body weight; this
inﬂuence will obviously affect also the development of the Metabolic Syndrome
which is strongly associated with impaired insulin sensitivity. Animal studies have
clearly shown that a high-fat diet, particularly if high in saturated fat, decreases
insulin sensitivity. Several cross-sectional studies have examined dietary fat in
Treatment of Diabetes with Lifestyle Changes: Diet 11
relation to fasting and post-load plasma insulin concentrations, which are both
markers of insulin resistance. The consistent ﬁnding is a positive association
between saturated fat intake and hyperinsulinemia, independently of body fat.
These data have been partly conﬁrmed in human intervention studies using more
accurate techniques to evaluate insulin resistance. Why dietary fat quality can
inﬂuence insulin sensitivity is not completely understood; however, the effects of
dietary fatty acids on insulin sensitivity are thought to be mediated, at least partially,
by the fatty acid composition of cell membranes (Riccardi et al. 2004). A speciﬁc
fatty acid proﬁle in cell membranes could inﬂuence insulin action through several
potential mechanisms, including altered insulin receptor binding or afﬁnity, and by
inﬂuencing ion permeability and cell signaling. Insulin resistant states are associated
with a plasma fatty acid pattern characterized by an increased proportion of palmitic
acid and a low proportion of linoleic acid, with a distribution of other fatty acids that
indicates an increased activity of D9- and D6-desaturases. These changes are
possibly related, to a large extent, to the type of fat in the diet and are consistent
with a diet where animal (saturated) fat consumption is increased and vegetable
(unsaturated) fat consumption is reduced. The deteriorating effect of saturated fat on
insulin sensitivity is supported by controlled intervention studies in which the
comparison was performed between saturated fat and either monounsaturated or
polyunsaturated fat (Vessby et al. 2001).
Looking at the association between dietary pattern and risk of type 2 diabetes,
data from epidemiological study have shown that an higher adherence to a Medi-
terranean dietary pattern is associated with a signiﬁcant reduction by 12% of type 2
Table 2 Foods, nutrients and dietary patterns associated with risk of developing type 2 diabetes
Increased risk
Degree of
evidence Decreased risk
Degree of
evidence
Foods Soft drinks ++ Whole grains ++
Red meat and
processed meat
++ Tea and coffee ++
Oil and hydrogenated
margarines
+ Milk and dairy
products low in fat
++
Eggs + Fruits, vegetables,
legumes
++
High alcohol
consumption
++ Moderate alcohol
consumption
+
Nuts +
Nutrients Saturated fatty acids + Fibers ++
Trans fatty acids + Unsaturated fatty acids ++
Antioxidants +
Magnesium +
Dietary
patterns
High glycemic load ++ Mediterranean diet +++
Western diet ++
Degree of evidence from prospective epidemiological studies = þþþ High;þþ Moderate; þ
Reasonable
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diabetes risk compared with individuals with lower adherence to Mediterranean diet
in a large cohort of healthy subjects from Mediterranean and non-Mediterranean
countries (InterAct Consortium et al. 2011).
The role of dietary patterns and, in particular, of the Mediterranean diet in
reducing type 2 diabetes risk has been clearly reinforced by the results of the
PREDIMED study (Salas-Salvadó et al. 2011). After a median follow-up of
4 years, a multivariable adjusted hazard ratio for the incidence of type 2 diabetes
was almost 50% lower in the participants assigned to the MedD as compared to the
control diet. In addition, increased adherence to MedD was inversely associated with
the development of diabetes. It has to be underlined that in this study the reduction of
type 2 diabetes was observed in absence of any signiﬁcant changes in body weight or
physical activity, suggesting that the mechanisms involved in diabetes risk reduction
in this study are independent from body weight loss and could be related to an
improvement in insulin sensitivity and/or a reduction of oxidative stress and
inﬂammation.
In addition to the effect of diet composition, new data from the Diabetes Preven-
tion Study (DPS) have further outlined the importance of more global lifestyle
modiﬁcations on the reduction of type 2 diabetes; in fact, the beneﬁts of moderate
weight reduction, together with an increase of physical activity and changes in diet
composition, are preserved in the long term, even many years after the conclusion of
the intervention (Lindström et al. 2013).
Although lifestyle interventions are not easily applicable in real-life, the Euro-
pean Diabetes Prevention Study (EDIPS) has recently shown that the Finnish DPS
protocol can be applicable with success in other European countries reducing by
57% the cumulative type 2 diabetes incidence during a mean follow-up of 3.1 years
(Penn et al. 2013).
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